|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.29 USD | +2.46% |
|
-9.31% | +41.07% |
| 07-16 | Deutsche Bank Adjusts Price Target on Denali Therapeutics to $35 From $31, Maintains Buy Rating | MT |
| 07-14 | Biogen's Alzheimer's drug lowers toxic protein, but results were mixed | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.46% | -9.31% | -0.09% | +13.22% | +41.07% | +66.36% | -21.58% | -63.86% | - | 3.7B | |
| +0.24% | -1.54% | -1.42% | +4.76% | +4.91% | +52.85% | +71.85% | +190.35% | +5,562.65% | 53.83B | |
| -7.17% | -4.39% | +14.77% | +18.61% | +30.06% | +42.72% | +73.32% | -28.59% | - | 52.1B | |
| +0.80% | -6.31% | +13.07% | -25.03% | -37.76% | +5.62% | +417.78% | +306.30% | +844.38% | 23.48B | |
| -0.09% | -0.01% | +0.65% | -11.12% | -3.91% | -16.85% | -15.41% | -60.48% | - | 23.13B | |
| -5.95% | -2.58% | +19.99% | +3.53% | +17.62% | +29.53% | -9.47% | -73.57% | - | 19.36B | |
| -1.14% | +0.03% | +14.87% | +3.60% | -7.79% | +31.67% | -30.65% | -31.46% | +63.66% | 17.56B | |
| -5.16% | -7.00% | +25.06% | +103.00% | +182.04% | +168.44% | +314.96% | +1,565.96% | +600.50% | 15.2B | |
| -6.91% | -5.83% | +16.98% | -6.46% | +24.02% | +25.17% | +644.30% | - | - | 14.83B | |
| +0.43% | -1.03% | +7.72% | +24.57% | +27.58% | +25.75% | +189.74% | +232.86% | +564.13% | 14.06B | |
| +1.46% | +3.13% | +9.44% | +4.03% | -4.96% | +65.65% | +152.36% | +489.62% | - | 12.76B | |
| -0.22% | -5.53% | +1.78% | +20.19% | +26.19% | +115.36% | +141.58% | +316.95% | +721.52% | 10.89B | |
| +0.36% | -9.44% | +0.44% | -45.09% | -21.04% | -47.29% | +548.36% | +95.06% | +89.18% | 10.72B | |
| +4.10% | -2.75% | -9.19% | +6.89% | +11.91% | +343.32% | +112.35% | +17.14% | +1,161.46% | 10.47B | |
| -13.21% | -9.15% | +0.91% | -41.49% | -21.81% | -37.21% | +140.74% | +52.20% | - | 10.38B | |
| -0.06% | +0.34% | +133.79% | +104.54% | +80.15% | +169.56% | +320.56% | +325.25% | - | 8.84B | |
| +6.49% | +2.55% | +13.46% | +37.28% | +205.95% | +515.29% | +492.55% | -40.78% | -10.51% | 8.81B | |
| +0.29% | -3.45% | +9.25% | -9.86% | +21.80% | +55.21% | +20.34% | +161.40% | - | 8.12B | |
| -10.29% | -9.33% | +11.31% | -36.41% | +5.90% | +7.77% | +77.74% | -28.80% | - | 8.07B | |
| +3.09% | -6.57% | +4.35% | -0.26% | +287.88% | +179.27% | +158.59% | -29.09% | - | 8.04B | |
| Average | -1.52% | -3.66% | +14.36% | +8.43% | +43.49% | +89.91% | +190.00% | +178.76% | +1,066.33% | 16.72B | |
| Weighted average by Cap. | -2.15% | -2.87% | +11.86% | +8.03% | +28.95% | +66.60% | +163.28% | +169.67% | +2,171.52% |
- Stock Market
- Stocks
- DNLI Stock
- Sector Denali Therapeutics Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
